Edison Investment Research - APQ Global (APQ) Building an emerging markets business

Report

Edison Investment Research

Building an emerging markets business

Since listing in August 2016 with the issue of £78m in equity, APQ Global has moved quickly but cautiously to deploy the funds. It has initially assembled a highly diversified liquid markets portfolio of predominantly bonds and equities in global emerging markets, including a number of strategic positions, while working on the sourcing of direct investments. APQ is managed by an experienced and incentivised team aiming to deliver a sustainable, progressive dividend with the potential for capital growth from investments in emerging markets.

07/08/2017 12 EN

Underlying

APQ Global

APQ Global is engaged in building growing businesses in emerging markets. Co. focuses its activities in emerging markets globally (in Asia, Latin America, Eastern Europe, the Middle East and Africa).

See profile

GG00BZ6VP173 London Stock Exchange Guernsey

Provider

Edison Investment Research

Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

See profile

Other Reports on these Companies

SmartInsider

Apq Global Limited: 1 director

A director at Apq Global Limited bought 190,500 shares at 13p and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of boar...

Free Trial

August 11, 2021 August 11, 2021 1 EN

Edison Investment Research

APQ Global - CULS issuance and income target achieved

Following shareholder approval at the December EGM, APQ has issued an additional Â£10.3m in 3.5% convertible unsecured loan stocks (CULS) at a 3% premium to par value. The CULS provide long-term structural gearing at a fixed cost, the proceeds of which will be deployed in line with the companyâ€™s business and investment strategy. APQ has also changed its reporting currency from sterling to US dollars so as to more closely match its investments. Separately, it has reported an unaudited 31 December net book value per share of US$128.1 and declared a fourth quarterly DPS of 1.5p. Total DPS of 6....

January 29, 2018 January 29, 2018 3 EN

Edison Investment Research

APQ Global - Meeting income targets and looking to grow

APQ Global is well on track to deliver its targeted 6% yield on its August 2016 IPO price of 100p. The proceeds from the IPO and follow-on CULS issue have initially already been invested in a highly diversified liquid markets portfolio of mainly global emerging market bonds and equities, including a number of strategic positions. APQ continues to work on the sourcing of direct investments. The management team is experienced and incentivised, and supported by an advisory group of international EM experts. It aims to deliver a sustainable, progressive dividend with the potential for capital grow...

December 11, 2017 December 11, 2017 8 EN

AGBA - A transformational deal

On 18 April, AGBA, announced a surprise deal to acquire 100% of Triller Corp, a global AI-driven social video platform, in an all-stock transaction. Triller is privately-owned but has been independently valued at US$3.2bn. AGBA’s management is using a US$4bn valuation for the combined entity, in which AGBA shareholders will own 20% and Triller shareholders 80%. Triller recorded FY23 revenues of US$45m on 450m user accounts and 2.2m creators but is loss-making. In FY23, AGBA reported revenues of US$54m and 400,000+ clients. The combined group expects synergies from expanding and marketing to Tr...

2h / 24m 2h / 24m 1 EN

Sean Conroy

Sean Conroy

Biodexa Pharmaceuticals - In a period of transition

FY23 was a transitional year for Biodexa, following the restructuring announced in March 2023 into a therapeutic company from a drug delivery specialist, and the implementation of cost-saving initiatives in light of the macroeconomic environment. The pipeline expansion primarily de-risks the business, partially fulfilled with the acquisition of lyn kinase activator tolimidone, for type 1 diabetes (T1D), in late 2023. Management estimates gross cash of £5.97m at end-FY23 to provide a runway into Q424, past the planned Phase IIa trial initiation for tolimidone. The next catalyst will likely be t...

6h / 33m 6h / 33m 1 EN

Toby Thorrington

Toby Thorrington

Norcros - Sale of Johnson Tiles UK agreed

Norcros’s disposal of Johnson Tiles is the latest strategic activity taken by management to better allocate capital to fit with priorities. Last year it closed its UK adhesives operation. Norcros has a compelling investment case, where its new product development initiatives, market positioning and self-help initiatives allow it to take market share in both the UK and South Africa. Its rating is low at 6.0x FY24e P/E, which is attractive, especially when compared to its yield of 5.4% on its well-covered dividend. We retain our estimates and value the shares at 246p, implying c 30% upside.

April 25, 2024 April 25, 2024 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Building an emerging markets business

Apq Global Limited: 1 director

APQ Global - CULS issuance and income target achieved

APQ Global - Meeting income targets and looking to grow

AGBA - A transformational deal

Biodexa Pharmaceuticals - In a period of transition

Norcros - Sale of Johnson Tiles UK agreed

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe